Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-15
1998-12-22
Huang, Evelyn
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514218, 514256, 514299, 514318, 514341, 514351, 514396, 514397, 514326, 544316, 546112, 546193, 546194, 546210, 5462784, 5483147, A61K 31445, A61K 31495, C07D40106, C07D40114
Patent
active
058520457
ABSTRACT:
Fibrinogen receptor antagonists having the structure, for example, of ##STR1## for example ##STR2##
REFERENCES:
patent: 3322631 (1967-05-01), Sprague et al.
patent: 4010274 (1977-03-01), Giraldi et al.
patent: 4313947 (1982-02-01), Nakagawa et al.
patent: 5030654 (1991-07-01), Barnish et al.
patent: 5037808 (1991-08-01), Tjoeng et al.
patent: 5051405 (1991-09-01), Klein et al.
patent: 5264420 (1993-11-01), Duggan et al.
patent: 5272158 (1993-12-01), Hartman et al.
patent: 5281585 (1994-01-01), Duggan et al.
patent: 5321034 (1994-06-01), Duggan et al.
patent: 5334596 (1994-08-01), Hartman et al.
Sugimoto et al., Journal of Medicinal Chemistry, "7-(Ethoxycarbonyl)-6,8-dimethyl-2-phenyl-" etc., 27, 1300-1305 (1984).
Askew Ben C.
Duggan Mark E.
Egbertson Melissa S.
Halczenko Wasyl
Hartman George D.
Huang Evelyn
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2048075